Philippe Genne
Chief Executive Officer presso ONCODESIGN PRECISION MEDICINE
Profilo
Philippe Genne is the founder of Oncodesign Services SA, which was founded in 1995.
He currently holds the position of Chairman & Chief Executive Officer at Oncodesign Precision Medicine SA, Chairman at Oncodesign Usa, Inc., PK, Director at Oncodesign, Inc., Director at Centre Georges François Leclerc, Director at GIE Pharm'image, Director at Synergie MTL Inc., President at L'Association Française des Société de Services, Co-Manager at Sc Pcg, and Manager at Sci Nag.
He previously held the position of Director at Bpifrance SA, Project Manager at Debiopharm International SA, Associate at Glaxo-Welcomes' Research Institute, and Member-Supervisory Board at Synthelis SAS.
He obtained a doctorate degree from the University of Dijon.
Posizioni attive di Philippe Genne
| Società | Posizione | Inizio |
|---|---|---|
| ONCODESIGN PRECISION MEDICINE | Chief Executive Officer | 31/08/2022 |
| Oncodesign, Inc. | Director/Board Member | - |
| Centre Georges François Leclerc | Director/Board Member | - |
GIE Pharm'image
 GIE Pharm'image Miscellaneous Commercial ServicesCommercial Services GIE Pharm'image operates as a platform for pharmacology. The private company is based in Dijon, France. | Director/Board Member | - |
| L'Association Française des Société de Services | President | - |
Sci Nag
 Sci Nag Real Estate DevelopmentFinance Sci Nag engages in the rental of land and other real estate properties. The private company is based in Paris, France. | Corporate Officer/Principal | - |
Oncodesign Usa, Inc.
 Oncodesign Usa, Inc. Pharmaceuticals: MajorHealth Technology Oncodesign USA, Inc. manufactures pharmaceutical products. The private company is based in Cambridge. | Chairman | - |
Sc Pcg
 Sc Pcg Investment ManagersFinance Sc Pcg provides fund management services. | Corporate Officer/Principal | - |
| Synergie MTL Inc. | Director/Board Member | - |
| ░░░░░░░░░░ ░░░░ | ░░░░░░░░ | - |
Precedenti posizioni note di Philippe Genne
| Società | Posizione | Fine |
|---|---|---|
| ░░░░░░░░░░ ░░░░░░░░ ░░ | ░░░░░░░ | - |
| ░░░░░░░░░░░░░░░░░░░░ ░░░░░░░░ ░░░░░░░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | - |
| ░░░░░░░░░ ░░░ | ░░░░░░░░░░░░░░ ░░░░░░ | - |
| ░░░░░░░░░░ ░░░░░░░░░░░░░ ░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | - |
| ░░░░░░░░░ ░░ ░░░░░ | ░░░░░░░░░░░░░░ ░░░░░░ | - |
Formazione di Philippe Genne
| University of Dijon | Doctorate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Società quotate in Borsa | 1 |
|---|---|
| ONCODESIGN PRECISION MEDICINE | Health Technology |
| Aziende private | 14 |
|---|---|
Debiopharm International SA
 Debiopharm International SA Pharmaceuticals: MajorHealth Technology Debiopharm International SA operates as a biopharmaceutical development company with focus on biologics and drug evaluation, licensing and development. It formulates and develops products for the treatment of cancer, endometriosis, uterine fibroids and hepatitis. The company was founded in 1979 and is headquartered in Lausanne, Switzerland. | Health Technology |
| Glaxo-Welcomes' Research Institute | |
Bpifrance SA /Old/
 Bpifrance SA /Old/ Financial ConglomeratesFinance Bpifrance SA provides financial services. It includes bank, private equity, export credit agency, and coach for entrepreneurs. The company is headquartered in Maisons-Alfort, France. | Finance |
Synthelis SAS
 Synthelis SAS Pharmaceuticals: MajorHealth Technology Synthelis SAS manufactures membrane proteins. It specializes in the production, purification, and characterization of custom membrane proteins. The firm's services Membrane Protein (MP) expression, proteoliposomes, MP in detergents, feasibility study, and quality controls. Synthelis' technology enables the embedding of membrane proteins in liposomes directly during the translation step, allowing the production of active ready-to-use proteoliposomes. The company was founded by Bruno Tillier and Jean-Luc Lenormand in January 2011 and is headquartered in La Tronche, France. | Health Technology |
| Oncodesign, Inc. | |
| Centre Georges François Leclerc | |
GIE Pharm'image
GIE Pharm'image Miscellaneous Commercial ServicesCommercial Services GIE Pharm'image operates as a platform for pharmacology. The private company is based in Dijon, France. | Commercial Services |
| L'Association Française des Société de Services | |
Sc Pcg
Sc Pcg Investment ManagersFinance Sc Pcg provides fund management services. | Finance |
Sci Nag
Sci Nag Real Estate DevelopmentFinance Sci Nag engages in the rental of land and other real estate properties. The private company is based in Paris, France. | Finance |
Oncodesign Usa, Inc.
Oncodesign Usa, Inc. Pharmaceuticals: MajorHealth Technology Oncodesign USA, Inc. manufactures pharmaceutical products. The private company is based in Cambridge. | Health Technology |
| Synergie MTL Inc. | |
PK/PDesign SASU
 PK/PDesign SASU Miscellaneous Commercial ServicesCommercial Services PK/PDesign SASU engages in the research and development of biotechnology. The private company is based in Dijon, France. | Commercial Services |
Oncodesign Services SA
 Oncodesign Services SA Miscellaneous Commercial ServicesCommercial Services Oncodesign Services SA is a contract research organization that specializes in drug discovery and preclinical services. The company is based in Dijon, France, and has subsidiaries in Canada. The French company contributes to the development of innovative therapies in oncology, inflammation, and infectious diseases through integrated capabilities in medicinal chemistry, DMPK, pharmaco-imaging, bioanalysis, and in vivo/in vitro pharmacology. The company was founded in 1995 by Philippe Genne, and Fabrice Viviani has been the CEO of the company since December 01, 2022. | Commercial Services |
- Borsa valori
- Insiders
- Philippe Genne
